When did Bio-Techne report Q3 2025 earnings?

Bio-Techne (TECH) reported Q3 2025 earnings on May 7, 2025 before market open.

What were Bio-Techne's Q3 2025 revenue and EPS?

Bio-Techne reported revenue of $316.2M and diluted EPS of $0.56 for Q3 2025.

Did Bio-Techne beat estimates in Q3 2025?

Revenue missed the consensus estimate of $325.5M by $9.3M. EPS beat the consensus estimate of $0.51 by $0.05.

How did Bio-Techne's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 4.2% from $303.4M a year earlier and diluted EPS grew 16.7% from $0.48.

Where can I find Bio-Techne's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0001558370-25-006990) directly on SEC EDGAR. The filing index links above go to sec.gov.

Bio-Techne TECH Q3 2025 earnings

Reported May 7, 2025 · Before market open

Revenue$316.2MMiss by $9.3M Diluted EPS$0.56Beat by $0.05

Revenue estimate$325.5M

EPS estimate$0.51

Next report

Aug 5, 2026 (in a month)

Revenue estimate$314.4M

EPS estimate$0.53

Financials

Q3 2025

Income statement

See full

Revenue$316.2M+4.2%

Gross profit$214.6M+4.9%

Operating income$38.7M-42.2%

Net income$22.6M-54.0%

EPS (diluted)$0.14-54.8%

Balance sheet

See full

Cash & equivalents$140.7M+0.5%

Total debt$423.5M-14.4%

Total equity$2.0B+0.2%

Total assets$2.6B-2.8%

Cash flow

See full

Operating cash flow$41.1M-49.2%

CapEx$10.1M-38.4%

Free cash flow$31.0M-52.0%

Valuation & ratios

Q3 2025

Valuation

See full

Market cap$9.27B-16.3%

Enterprise value$9.55B-16.4%

P/E70.4×+15.8×

P/S7.7×-1.9×

Profitability

See full

Gross margin65.8%-1.0pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin18.3%-3.5pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.2×0.0×

Current ratio3.7×-0.4×

Segments

By product

See full

Consumables$257.8M+4.5%

Service$27.2M+6.8%

Instruments$26.1M-1.4%

Royalty$5.0M+7.2%

By geography

See full

US$181.9M—

CN$24.5M—

GB$12.9M—

By segment

See full

Protein Sciences$227.7M+6.1%

Diagnostics And Spatial Biology$89.2M+2.0%

Versus estimates

Revenue

Q3 2026$311.4MMiss by $4.7M Q2 2026$295.9MBeat by $5.4M Q1 2026$286.6MMiss by $4.8M Q4 2025$317.0MBeat by $22.3M

Q3 2025$316.2MMiss by $9.3M

Q2 2025$297.0MMiss by $20.5M

Diluted EPS

Q3 2026$0.53Miss by $0.02 Q2 2026$0.46Beat by $0.03 Q1 2026$0.42Miss by $0.00 Q4 2025$0.53Beat by $0.03

Q3 2025$0.56Beat by $0.05

Q2 2025$0.42Beat by $0.03

Ask the moment Bio-Techne reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Bio-Techne report Q3 2025 earnings?: Bio-Techne (TECH) reported Q3 2025 earnings on May 7, 2025 before market open.
What were Bio-Techne's Q3 2025 revenue and EPS?: Bio-Techne reported revenue of $316.2M and diluted EPS of $0.56 for Q3 2025.
Did Bio-Techne beat estimates in Q3 2025?: Revenue missed the consensus estimate of $325.5M by $9.3M. EPS beat the consensus estimate of $0.51 by $0.05.
How did Bio-Techne's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 4.2% from $303.4M a year earlier and diluted EPS grew 16.7% from $0.48.
Where can I find Bio-Techne's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0001558370-25-006990) directly on SEC EDGAR. The filing index links above go to sec.gov.